Terms: = Kidney tumors AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
443 results:
1. Wide-Targeted Semi-Quantitative Analysis of Acidic Glycosphingolipids in Cell Lines and Urine to Develop Potential Screening Biomarkers for Renal Cell Carcinoma.
Maekawa M; Sato T; Kanno C; Sakamoto I; Kawasaki Y; Ito A; Mano N
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612906
[TBL] [Abstract] [Full Text] [Related]
2. Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology.
Chen R; Wu J; Che Y; Jiao Y; Sun H; Zhao Y; Chen P; Meng L; Zhao T
Eur J Med Res; 2024 Mar; 29(1):176. PubMed ID: 38491523
[TBL] [Abstract] [Full Text] [Related]
3. Post Renal Transplant Malignancies; A Basic Concept.
Nabi Z; Zahid T; Nabi R
J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
[TBL] [Abstract] [Full Text] [Related]
4. The Value of Dual-Energy Computed Tomography-Based Radiomics in the Evaluation of Interstitial Fibers of Clear Cell Renal Carcinoma.
Bing X; Wang N; Li Y; Sun H; Yao J; Li R; Li Z; Ouyang A
Technol Cancer Res Treat; 2024; 23():15330338241235554. PubMed ID: 38404055
[TBL] [Abstract] [Full Text] [Related]
5. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
[TBL] [Abstract] [Full Text] [Related]
6. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract] [Full Text] [Related]
7. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
[TBL] [Abstract] [Full Text] [Related]
8. Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally.
Ali N; Amare E; Fekadu A; Awol M; Kayode O; Gebresenbet M; Nasir K; Dresser SA; Schriebmann E; Seife E; Esiashvili N
JCO Glob Oncol; 2024 Feb; 10():e2300345. PubMed ID: 38359372
[TBL] [Abstract] [Full Text] [Related]
9. Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma.
Li X; Deng X; Liu T; Zhang W; Tao J
Aging (Albany NY); 2024 Feb; 16(4):3280-3301. PubMed ID: 38334964
[TBL] [Abstract] [Full Text] [Related]
10. A novel model for predicting deep-seated candidiasis due to Candida glabrata among cancer patients: A 6-year study in a cancer center of China.
Li D; Wang L; Zhao Z; Bai C; Li X
Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38318635
[TBL] [Abstract] [Full Text] [Related]
11. Deciphering the Role of ERBB3 Isoforms in Renal Cell Carcinoma: A Comprehensive Genomic and Transcriptomic Analysis.
Kim M; Lee HH; Won SD; Jang Y; Kim BG; Cho NH; Choi YD; Chung JS; Han HH
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276060
[TBL] [Abstract] [Full Text] [Related]
12. Spice Up Your kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease.
Musolino M; D'Agostino M; Zicarelli M; Andreucci M; Coppolino G; Bolignano D
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255865
[TBL] [Abstract] [Full Text] [Related]
13. Epidemiology of and Risk Factors in Postoperative Complications from Robotically Assisted Laparoscopic Radical Prostatectomy in Contemporary National Surgical Quality Improvement Program Data.
Homer A; Golijanin B; Schmitt P; Bhatt V; Pareek G; Hyams ES
J Endourol; 2024 Mar; 38(3):270-275. PubMed ID: 38251639
[No Abstract] [Full Text] [Related]
14. Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line treatment for Advanced Renal Cell Carcinoma in Japan.
Maeda T; Moriwaki K; Morimoto K; Mo X; Yoshioka T; Goto R; Shimozuma K
Value Health Reg Issues; 2024 Mar; 40():118-126. PubMed ID: 38194896
[TBL] [Abstract] [Full Text] [Related]
15. Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy.
Zhou Z; Lin Z; Wang M; Wang L; Ji Y; Yang J; Yang Y; Zhu G; Liu T
Eur J Med Res; 2024 Jan; 29(1):12. PubMed ID: 38173048
[TBL] [Abstract] [Full Text] [Related]
16. RUNX3 pathway signature predicts clinical benefits of immune checkpoint inhibition plus tyrosine kinase inhibition in advanced renal cell carcinoma.
Wang J; Zhang S; Wang Y; Zhu Y; Xu X; Guo J
BMC Urol; 2024 Jan; 24(1):8. PubMed ID: 38172737
[TBL] [Abstract] [Full Text] [Related]
17. Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma.
Zhang Q; Lin B; Chen H; Ye Y; Huang Y; Chen Z; Li J
Front Immunol; 2023; 14():1324205. PubMed ID: 38090559
[TBL] [Abstract] [Full Text] [Related]
18. A novel DNA methylation signature revealed GDF6 and RCC1 as potential prognostic biomarkers correlated with cell proliferation in clear cell renal cell carcinoma.
Xu Z; Wu Y; Zhao G; Jin B; Jiang P
Mol Biol Rep; 2023 Dec; 51(1):16. PubMed ID: 38087057
[TBL] [Abstract] [Full Text] [Related]
19. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
Chang Q; Sun J; Zhao S; Li L; Zhang N; Yan L; Fan Y; Liu J
Aging (Albany NY); 2023 Nov; 15(23):13753-13775. PubMed ID: 38048211
[TBL] [Abstract] [Full Text] [Related]
20. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
[Next]
